Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0282751 WHEAT CULTIVAR 01071783
The invention relates to the wheat cultivar designated 01071783. Provided by the invention are the seeds, plants and derivatives of the wheat cultivar...
2018/0282750 WHEAT CULTIVAR 01071570
The invention relates to the wheat cultivar designated 01071570. Provided by the invention are the seeds, plants and derivatives of the wheat cultivar...
2018/0282749 WHEAT CULTIVAR 01071782
The invention relates to the wheat cultivar designated 01071782. Provided by the invention are the seeds, plants and derivatives of the wheat cultivar...
2018/0282748 WHEAT CULTIVAR 01071784
The invention relates to the wheat cultivar designated 01071784. Provided by the invention are the seeds, plants and derivatives of the wheat cultivar...
2018/0282747 WHEAT CULTIVAR 01071789
The invention relates to the wheat cultivar designated 01071789. Provided by the invention are the seeds, plants and derivatives of the wheat cultivar...
2018/0282746 WHEAT CULTIVAR WB9350
The invention relates to the wheat cultivar designated WB9350. Provided by the invention are the seeds, plants and derivatives of the wheat cultivar WB9350....
2018/0282745 COTTON VARIETY 16R023
The invention relates to the novel cotton variety designated 16R023. Provided by the invention are the seeds, plants, plant parts and derivatives of the cotton...
2018/0282744 METHODS OF INCREASING CROP YIELD UNDER ABIOTIC STRESS
Methods and materials for increasing abiotic stress tolerance in plants are disclosed. For example, nucleic acids encoding abiotic stress tolerance-increasing...
2018/0282743 Methods and Compositions for Increasing Invertase Activity in Plants
The present invention provides novel compositions for use to enhance crop performance. Specifically, the present invention provides for increased invertase...
2018/0282742 WHEAT CULTIVAR 01071571
The invention relates to the wheat cultivar designated 01071571. Provided by the invention are the seeds, plants and derivatives of the wheat cultivar...
2018/0282741 WHEAT CULTIVAR 01071780
The invention relates to the wheat cultivar designated 01071780. Provided by the invention are the seeds, plants and derivatives of the wheat cultivar...
2018/0282740 WHEAT CULTIVAR 01071514
The invention relates to the wheat cultivar designated 01071514. Provided by the invention are the seeds, plants and derivatives of the wheat cultivar...
2018/0282738 COMPOSITIONS FOR ADJUSTABLE RIBOSOME TRANSLATION SPEED AND METHODS OF USE
The present invention relates to the effects of codon context and synonymous codon changes on mRNA translation and methods of increasing protein production.
2018/0282737 UNCOUPLING GROWTH AND PROTEIN PRODUCTION
The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to...
2018/0282736 HER3 VACCINE VECTOR COMPOSITIONS AND METHODS OF USING THE SAME
The present inventors provide HER3 vaccine vector compositions and methods of using the same. More specifically, the present inventors demonstrate, in part,...
2018/0282735 PHARMACEUTICAL COMPOSITION FOR NEURODEGENERATIVE BRAIN DISEASE AND SCREENING METHOD FOR THE SAME
The present invention provides a therapeutic composition for prevention or treatment of neurodegenerative brain disease caused by traumatic brain injury,...
2018/0282734 METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEAD AND NECK CANCER
Disclosed are methods of treating a head and/or neck squamous cell carcinoma in an individual. The method may include the step of administering to an...
2018/0282733 THERAPEUTIC AGENT FOR SARCOPENIA AND METABOLIC DISEASES
The present invention provides a therapeutic agent for a muscle weakness symptom (sarcopenia) or a metabolic disease, containing a .mu.-crystallin (CRYM)...
2018/0282732 COMPOSITIONS AND METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)
The present invention relates to small interfering RNA (siRNA) molecules against the SOD1 gene, adeno-associated viral (AAV) vectors encoding siRNA molecules...
2018/0282731 OLIGONUCLEOTIDES FOR MODULATING GENE EXPRESSION AND USES THEREOF
The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of...
2018/0282730 LIN28/LET-7 CRYSTAL STRUCTURES, PURIFICATION PROTOCOLS, AND MOLECULAR PROBES SUITABLE FOR SCREENING ASSAYS AND...
The invention provides compositions and methods for regulating microRNA (miRNA) biogenesis. The invention also relates to compositions and methods for treating...
2018/0282729 APTAMERS FOR THE TREATMENT OF SICKLE CELL DISEASE
The present invention provides polynucleotide aptamers that selectively bind to and inhibit polymerization of sickle hemoglobin (HbS), pharmaceutical...
2018/0282728 ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
The present disclosure relates to RNAi agents useful in methods of treating Beta-Catenin-related diseases such as adenomatous polyposis of the colon,...
2018/0282727 PLANT-MEDIATED SILENCING OF A FATTY ACID AND RETINOID BINDING PROTEIN IN PRATYLENCHUS PENETRANS
The present disclosure provides compositions and methods utilizing double strand ribonucleic acid (dsRNA) to control parasitic nematodes, including ...
2018/0282726 BIOACTIVE RENAL CELLS
The present invention concerns bioactive renal cells populations, renal cell constructs, and methods of making and using the same.
2018/0282725 Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid A Gene
The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting a Serum Amyloid A (SAA) gene, and methods of using the dsRNA to inhibit...
2018/0282724 USE OF SINGLE-STRANDED ANTISENSE OLIGONUCLEOTIDE IN PREVENTION OR TREATMENT OF GENETIC DISEASES INVOLVING A...
The invention relates to antisense oligonucleotides (AONs) comprising repetitive trinucleotide units for use in the treatment or prevention of genetic eye...
2018/0282723 METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF ANTITHROMBIN 3 (AT3) BY DOUBLE-STRANDED RNA
This invention relates to compounds, compositions, and methods useful for reducing AT3 target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate...
2018/0282722 Chimeric DNA:RNA Guide for High Accuracy Cas9 Genome Editing
A chimeric DNA:RNA guide for very high accuracy Cas9 genome editing employs nucleotide-type substitutions in nucleic acid-guided endonucleases for enhanced...
2018/0282721 DE NOVO SYNTHESIZED COMBINATORIAL NUCLEIC ACID LIBRARIES
Disclosed herein are methods for the generation of highly accurate nucleic acid libraries encoding for predetermined variants of a nucleic acid sequence. The...
2018/0282720 COMPOSITIONS AND METHODS FOR MULTIPLEXED QUANTITATIVE ANALYSIS OF CELL LINEAGES
Compositions and methods are provided for measuring population size for a plurality of clonal cell populations in the same individual, e.g., for measuring...
2018/0282719 ANTIGEN-BINDING MOLECULE CAPABLE OF BINDING TWO OR MORE ANTIGEN MOLECULES REPEATEDLY
The present inventors discovered that antibodies having weaker antigen-binding activity at the early endosomal pH in comparison with that at the pH of plasma...
2018/0282718 ANTIGEN-BINDING MOLECULE CAPABLE OF BINDING TWO OR MORE ANTIGEN MOLECULES REPEATEDLY
The present inventors discovered that antibodies having weaker antigen-binding activity at the early endosomal pH in comparison with that at the pH of plasma...
2018/0282717 POROUS SOLID PHASE FOR RAPIDLY ISOLATING BIOLOGICAL MOLECULES FOR NUCLEIC ACID AMPLIFICATION REACTION FROM...
A method for rapidly isolating a biological molecule for a nucleic acid amplification reaction from a biological sample, the method comprising: putting a...
2018/0282716 NITRILE HYDRATASE
Provided is an improved nitrile hydratase with improved catalytic activity. Also provided are DNA for coding the improved nitrile hydratase, a recombinant...
2018/0282715 NOVEL CRISPR-ASSOCIATED (CAS) PROTEIN
A new CRISPR-associated (Cas) protein, termed "CasM," is described, as well as polynucleotides encoding the same and methods of using CasM for site-specific...
2018/0282714 Engineered CRISPR-Cas9 Nucleases with Altered PAM Specificity
Engineered CRISPR-Cas9 nucleases with altered and improved PAM specificities and their use in genomic engineering, epigenomic engineering, and genome targeting.
2018/0282713 NUCLEASE-MEDIATED GENOME EDITING
The invention relates to the field of genetic engineering tools, methods and techniques for gene or genome editing. Specifically, the invention concerns...
2018/0282712 TRANSGLUTAMINASE VARIANTS HAVING INCREASED SPECIFIC ACTIVITY
A variant transglutaminase having increased specific activity compared to wild-type Streptomyces mobaraensis transglutaminase can be used for conjugating...
2018/0282711 PRODUCTION OF OMEGA 3 LONG CHAIN POLYUNSATURATED FATTY ACIDS IN OILSEED CROPS BY A THRAUSTOCHYTRID PUFA SYNTHASE
This disclosure concerns recombinant host organisms genetically modified with a polyunsaturated fatty acid (PUFA) synthase system and one or more accessory...
2018/0282710 FERULOYL-COA:MONOLIGNOL TRANSFERASES
The invention relates to feruloyl-CoA:monolignol transferase enzymes and nucleic acids encoding the feruloyl-CoA:monolignol transferase enzymes. The enzymes...
2018/0282709 PIPECOLINIC ACID 4-HYDROXYLASE AND METHOD FOR PRODUCING 4-HYDROXY AMINO ACID USING SAME
The present invention provides a pipecolic acid 4-hydroxylase protein exemplified by the following (A), (B), and (C), having activity to react with L-pipecolic...
2018/0282708 LACCASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME
The present invention relates to laccase variants comprising a substitution at one or more positions corresponding to positions 9, 21, 37, 79, 102, 170, 175,...
2018/0282707 MUTANT-TYPE URICASE, PEG MODIFIED MUTANT-TYPE URICASE, AND APPLICATION THEREOF
A mutant-type uricase, PEG modified mutant-type uricase, and application thereof. The mutant-type uricase has a cysteine residue introduced by recombination,...
2018/0282706 NEW LACTALDEHYDE REDUCTASES FOR THE PRODUCTION OF 1,2-PROPANEDIOL
The present invention relates to new lactaldehyde reductase (LAR) enzymes useful for the production of 1,2-propane-diol and to microorganisms overexpressing...
2018/0282705 COMPOSITIONS AND METHODS FOR MEASURING BLOOD GLUCOSE LEVELS
In some embodiments, the present invention provides a protein comprising amino acids in the following sequence ...
2018/0282704 CULTIVATION OF HUMAN NOROVIRUSES
Embodiments of the disclosure concern systems, methods, and/or compositions for cultivation of mammalian viruses, including at least human noroviruses and...
2018/0282703 NOVEL BACTERIOPHAGE AND ANTIBACTERIAL COMPOSITION COMPRISING THE SAME
Provided is a novel bacteriophage .PHI.CJ23 (KCCM11365P). In addition, the present invention relates to an antibacterial composition including the...
2018/0282702 CHIMERIC ADENO-ASSOCIATED VIRUS/ BOCAVIRUS PARVOVIRUS VECTOR
The invention provides an isolated chimeric virus comprising bocavirus capsid protein and a recombinant adeno-associated viral (AAV) genome, an isolated rBoV...
2018/0282701 METHOD TO REDUCE ONCOGENIC POTENTIAL OF INDUCED PLURIPOTENT STEM CELLS FROM AGED DONORS
Disclosed are findings that: (a) induced pluripotent stem cells derived from aged donors (A-iPSC) show increased genomic instability, a defect in apoptosis, a...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.